LH Labcorp Holdings Inc. Common Stock
Über Labcorp Holdings Inc. Common Stock Unternehmensübersicht von Wikipedia
LabCorp ist ein US-amerikanisches Unternehmen das klinische Labordienstleistungen anbietet. Das Unternehmen liefert Laborbefunde für die Diagnostik von Erkrankungen und die Entwicklung neuer Arzneimittel.
Mehr lesen
LabCorp (offizielle Firma: Laboratory Corporation of America Holdings) ist ein US-amerikanisches Unternehmen das klinische Labordienstleistungen anbietet. Das Unternehmen liefert Laborbefunde für die Diagnostik von Erkrankungen und die Entwicklung neuer Arzneimittel.
Laboratory Corporation of America Holdings entstand 1995 durch eine Fusion zwischen den Unternehmen National Health Laboratories (NHL), eine ehemalige Tochter von Revlon, und Roche Biomedical Laboratories (RBL), ein ehemaliger Geschäftsbereich von Hoffmann-La Roche. Durch diese Fusion entstand mit LabCorp der weltweit größte Anbieter klinischer Labordienstleistungen. In den folgenden Jahren erfolgte eine Vielzahl von Unternehmensakquisen, wie die Übernahme von Covance im Jahr 2015.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
LH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
LH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 29. Mai 2026 | $0,7200 |
| 27. Februar 2026 | $0,7200 |
| 26. November 2025 | $0,7200 |
| 28. August 2025 | $0,7200 |
| 29. Mai 2025 | $0,7200 |
| 27. Februar 2025 | $0,7200 |
| 26. November 2024 | $0,7200 |
| 29. August 2024 | $0,7200 |
| 24. Mai 2024 | $0,7200 |
| 26. Februar 2024 | $0,7200 |
| 7. November 2023 | $0,7200 |
| 7. August 2023 | $0,7200 |
| 17. Mai 2023 | $0,6186 |
| 22. Februar 2023 | $0,6186 |
| 16. November 2022 | $0,6186 |
| 17. August 2022 | $0,6186 |
| 18. Mai 2022 | $0,6186 |
| 29. März 1994 | $0,1718 |
| 29. Dezember 1993 | $0,1718 |
| 29. September 1993 | $0,1718 |
LH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 9 33,3%
- Kauf 12 44,4%
- Halten 6 22,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
16 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $4.99 | $4.92 | 0.07% |
| 31. März 2026 | $4.25 | $4.21 | 0.04% |
| 31. Dezember 2025 | $4.07 | $4.06 | 0.01% |
| 30. September 2025 | $4.18 | $4.26 | -0.08% |
| 30. Juni 2025 | $4.35 | $4.29 | 0.06% |
| 31. März 2025 | $3.84 | $3.85 | -0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B | $10.31B | $9.55B | $8.68B | $6.01B | |
| Cost of Revenue | $9.94B | $9.38B | $8.80B | $8.15B | $8.14B | $9.03B | $8.30B | $8.16B | $7.22B | $6.70B | $5.60B | $3.81B | |
| Gross Profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B | $3.25B | $3.18B | $3.09B | $2.85B | $2.90B | $2.20B | |
| SG&A Expense | $2.22B | $2.23B | $2.02B | $1.76B | $1.69B | $1.73B | $1.62B | $1.57B | $1.50B | $1.35B | $1.63B | $1.20B | |
| Operating Income | $1.38B | $1.09B | $726M | $1.44B | $3.05B | $2.45B | $1.33B | $1.33B | $1.31B | $1.27B | $997M | $910M | |
| Interest Expense | $224M | $208M | $200M | $180M | $212M | $207M | $241M | $244M | $235M | $219M | $275M | $110M | |
| Other Non-op | $-55M | $60M | $16M | $-32M | $16M | $-32M | $-3M | $168M | $-6M | $12M | $-8M | $10M | |
| Income Tax | $230M | $212M | $188M | $234M | $690M | $662M | $280M | $384M | $-155M | $361M | $287M | $314M | |
| Net Income | $876M | $746M | $418M | $1.28B | $2.38B | $1.56B | $824M | $884M | $1.23B | $712M | $438M | $511M | |
| EPS (Basic) | $10.54 | $8.89 | $4.80 | $14.05 | $24.60 | $15.99 | $8.42 | $8.71 | $11.99 | $6.94 | $4.43 | $6.03 | |
| EPS (Diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 | $15.88 | $8.35 | $8.61 | $11.81 | $6.82 | $4.35 | $5.91 | |
| Shares (Basic) | 83,200,000 | 83,900,000 | 87,100,000 | 91,100,000 | 96,700,000 | 97,300,000 | 97,900,000 | 101,400,000 | 102,400,000 | 102,500,000 | 98,800,000 | 84,800,000 | |
| Shares (Diluted) | 83,800,000 | 84,400,000 | 87,600,000 | 91,600,000 | 97,500,000 | 98,000,000 | 98,600,000 | 102,600,000 | 103,900,000 | 104,300,000 | 100,600,000 | 86,400,000 | |
| EBITDA | $2.07B | $1.73B | $1.30B | $2.41B | $4.00B | $3.07B | · | $1.88B | $1.90B | $1.81B | $1.46B | $1.16B |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $532M | $1.52B | $537M | $321M | $1.47B | $1.32B | $338M | $427M | $317M | $434M | $716M | $580M | |
| Receivables | $2.10B | $1.94B | $1.91B | $1.79B | $2.26B | $2.48B | $1.54B | $1.47B | $1.53B | $1.33B | $1.22B | $816M | |
| Inventory | $535M | $493M | $475M | $471M | $401M | $423M | $245M | $237M | $227M | $205M | $191M | $140M | |
| Prepaid Expense | $693M | $698M | $655M | $610M | $478M | $365M | $374M | $309M | $309M | $321M | $339M | $158M | |
| Current Assets | $4.02B | $4.81B | $3.77B | $4.62B | $5.33B | $5.13B | $2.98B | $2.84B | $2.73B | $2.48B | $2.62B | $1.69B | |
| PP&E (Net) | $3.08B | $3.05B | $2.91B | $2.79B | $2.82B | $2.73B | $2.64B | $1.74B | $1.71B | $1.72B | $1.75B | $786M | |
| PP&E (Gross) | $6.35B | $6.12B | $5.82B | $5.38B | $5.23B | $4.93B | $4.57B | $3.48B | $3.27B | $3.11B | $2.87B | $1.81B | |
| Accum. Depreciation | $3.27B | $3.07B | $2.91B | $2.58B | $2.41B | $2.20B | $1.93B | $1.74B | $1.56B | $1.39B | $1.12B | $1.03B | |
| Goodwill | $6.79B | $6.37B | $6.14B | $6.12B | $5.89B | $7.75B | $7.87B | $7.36B | $7.40B | $6.42B | $6.42B | $6.20B | |
| Intangibles | $3.60B | $3.49B | $3.34B | $3.12B | $3.74B | $3.96B | $4.03B | $3.91B | $4.17B | $3.40B | $3.32B | $1.48B | |
| Other Non-current Assets | $751M | $652M | $536M | $378M | $463M | $410M | $435M | $276M | $218M | $165M | $150M | $155M | |
| Total Assets | $18.39B | $18.38B | $16.73B | $20.16B | $20.39B | $20.07B | $18.05B | $16.19B | $16.67B | $14.25B | $14.10B | $7.30B | |
| Accounts Payable | $841M | $876M | $828M | $852M | $621M | $639M | $632M | $635M | $574M | $508M | $497M | $282M | |
| Accrued Liabilities | $848M | $871M | $804M | $787M | $1.40B | $1.36B | $942M | $870M | $793M | $594M | $633M | $341M | |
| Short-term Debt | $300.0K | $400.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $0 | · | · | |
| Current Liabilities | $2.82B | $3.33B | $3.23B | $3.08B | $2.78B | $3.08B | $2.66B | $1.88B | $2.19B | $1.83B | $1.70B | $976M | |
| Capital Leases | $683M | $676M | $649M | $653M | $642M | $678M | $597M | $0 | $58M | $56M | $56M | $39M | |
| Other Non-current Liabilities | $648M | $517M | $409M | $401M | $402M | $526M | $383M | $334M | $376M | $392M | $323M | $274M | |
| Total Liabilities | $9.76B | $10.31B | $8.83B | $10.04B | $10.09B | $10.61B | $10.46B | $9.19B | $9.85B | $8.73B | $9.14B | $4.46B | |
| Long-term Debt | $5.58B | $6.33B | · | · | · | · | $6.21B | $6.00B | $6.70B | $5.78B | $6.36B | $2.99B | |
| Total Debt | $5.58B | $5.33B | $4.05B | $5.04B | $5.42B | $5.42B | · | $6.05B | $6.76B | $5.84B | $6.41B | $3.03B | |
| Common Stock | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | |
| Retained Earnings | $8.64B | $8.30B | $7.89B | $10.58B | $10.46B | $9.48B | $7.98B | $7.16B | $6.20B | $4.97B | $4.22B | $3.79B | |
| Treasury Stock | · | · | · | · | · | · | $0 | $1.11B | $1.06B | $1.01B | $978M | $966M | |
| AOCI | $-28M | $-262M | $-59M | $-493M | $-192M | $-162M | $-372M | $-463M | $-334M | $-582M | $-287M | $-10M | |
| Stockholders' Equity | $8.62B | $8.05B | $7.88B | $10.10B | $10.27B | $9.44B | $7.64B | $7.05B | $6.80B | $5.52B | $4.95B | $2.82B | |
| Liabilities + Equity | $18.39B | $18.38B | $16.73B | $20.16B | $20.39B | $20.07B | $18.05B | $16.19B | $16.67B | $14.25B | $14.10B | $7.30B | |
| Shares Outstanding | 82,200,000 | 83,400,000 | 83,900,000 | 88,200,000 | 93,100,000 | 97,500,000 | 97,200,000 | 98,900,000 | 101,900,000 | 102,700,000 | 101,300,000 | 84,600,000 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $681M | $644M | $577M | $537M | $577M | $625M | $577M | $552M | $533M | $499M | $458M | $246M | |
| Stock-based Comp | $126M | $117M | $129M | $117M | $133M | $112M | $107M | $92M | $110M | $110M | $102M | $46M | |
| Deferred Tax | $98M | $-20M | $-78M | $24M | $-38M | $-47M | $29M | $33M | $-542M | $55M | $-34M | $28M | |
| Amort. of Intangibles | $280M | $256M | $220M | $194M | $230M | $275M | $243M | $232M | $216M | $180M | $164M | $77M | |
| Restructuring | · | · | $56M | $56M | $44M | $33M | $33M | $52M | $76M | $65M | $114M | $19M | |
| Other Non-cash | $-140M | $100M | $282M | $-108M | $-88M | $-110M | · | $-244M | $74M | $-220M | $19M | $-91M | |
| Operating Cash Flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B | $2.14B | $1.44B | $1.31B | $1.50B | $1.20B | $982M | $739M | |
| CapEx | $434M | $490M | $454M | $429M | $422M | $382M | $400M | $380M | $313M | $279M | $256M | $204M | |
| Investing Cash Flow | $-1.19B | $-1.37B | $-1.17B | $-1.65B | $-885M | $-643M | $-1.28B | $207M | $-2.23B | $-796M | $-3.99B | $-350M | |
| Debt Issued | · | · | · | $0 | $1.00B | $0 | $1.05B | $0 | $1.20B | $0 | $2.90B | $0 | |
| Net Debt Issued | · | · | · | $0 | $1.00B | $0 | · | $0 | $1.20B | $0 | $2.90B | $0 | |
| Stock Repurchased | $450M | $250M | $1.00B | $1.10B | $1.67B | $100M | $450M | $700M | $338M | $44M | $0 | $269M | |
| Net Stock Activity | $-450M | $-250M | $-1.00B | $-1.10B | $-1.67B | $-100M | · | $-700M | $-338M | $-44M | $0 | $-269M | |
| Dividends Paid | $241M | $243M | $254M | $195M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.46B | $780M | $-59M | $-1.32B | $-2.07B | $-517M | $-253M | $-1.39B | $593M | $-671M | $3.18B | $-201M | |
| Net Change in Cash | $-986M | $982M | $107M | $-1.04B | $152M | $983M | $-89M | $110M | $-117M | $-283M | $136M | $176M | |
| Taxes Paid | $171M | $215M | $207M | $475M | $965M | $500M | $217M | $350M | $348M | $346M | $238M | $284M | |
| Free Cash Flow | $1.21B | $1.10B | $874M | $1.47B | $2.65B | $1.75B | · | $926M | $1.15B | $897M | $727M | $536M |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.8% | 27.9% | 27.7% | 29.5% | 34.9% | 35.4% | · | 28.0% | 33.2% | 33.0% | 33.5% | 36.6% | |
| Operating Margin | 9.9% | 8.3% | 6.0% | 11.9% | 20.2% | 17.5% | · | 11.7% | 13.1% | 13.6% | 11.6% | 15.1% | |
| Net Margin | 6.3% | 5.7% | 3.4% | 8.6% | 14.8% | 11.1% | · | 7.8% | 12.2% | 7.6% | 5.0% | 8.5% | |
| EBITDA Margin | 14.8% | 13.3% | 10.7% | 16.2% | 24.8% | 22.0% | · | 16.6% | 18.2% | 18.8% | 16.8% | 19.2% | |
| ROA | 4.8% | 4.2% | 2.3% | 6.3% | 11.8% | 8.2% | · | 5.4% | 8.2% | 5.2% | 4.1% | 7.2% | |
| ROE | 10.3% | 9.2% | 5.3% | 12.7% | 22.8% | 17.7% | · | 12.4% | 19.6% | 13.2% | 9.0% | 18.3% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.2 | 1.5 | 1.9 | 1.7 | · | 1.5 | 1.3 | 1.4 | 1.6 | 1.7 | |
| Quick Ratio | 0.9 | 1.0 | 0.8 | 0.9 | 1.3 | 1.2 | · | 1.0 | 0.9 | 1.0 | 1.1 | 1.4 | |
| Debt / Equity | 0.6 | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | · | 0.9 | 1.0 | 1.1 | 1.3 | 1.1 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | · | 0.9 | 0.9 | 1.0 | 1.2 | 1.0 | |
| Interest Coverage | 6.2 | 5.2 | 3.6 | 9.8 | 15.4 | 11.8 | · | 5.4 | 5.8 | 6.0 | 3.6 | 8.3 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | · | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 19.3 | 19.4 | 18.6 | 24.1 | 25.5 | 27.0 | · | 35.1 | 31.2 | 31.6 | 33.9 | 27.6 | |
| Receivables Turnover | 6.9 | 6.7 | 6.6 | 6.6 | 6.8 | 6.9 | · | 7.6 | 7.4 | 7.6 | 8.5 | 7.5 |
Wachstumsraten 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 7.0% | 2.5% | -9.7% | -6.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | -0.32% | -4.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -0.04% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 18.3% | 85.3% | -65.9% | -42.7% | 53.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -9.2% | -28.7% | -33.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -8.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.5% | 78.5% | -67.3% | -46.2% | 52.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -11.8% | -32.0% | -35.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -10.8% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B | $10.31B | $9.55B | $8.68B | $6.01B | |
| Net Income TTM | $876M | $746M | $418M | $1.28B | $2.38B | $1.56B | $824M | $884M | $1.23B | $712M | $438M | $511M | |
| Market Cap | $20.62B | $19.13B | · | · | · | · | · | $10.74B | $13.96B | $11.33B | $10.76B | $7.84B | |
| Enterprise Value | $25.68B | $22.94B | · | · | · | · | · | $16.36B | $20.40B | $16.73B | $16.46B | $10.29B | |
| P/E | 24.0 | 25.9 | 47.6 | 14.5 | 11.1 | 11.0 | 17.4 | 12.6 | 11.6 | 16.2 | 24.4 | 15.7 | |
| P/S | 1.5 | 1.5 | · | · | · | · | · | 0.9 | 1.4 | 1.2 | 1.2 | 1.3 | |
| P/B | 2.4 | 2.4 | · | · | · | · | · | 1.5 | 2.0 | 2.1 | 2.2 | 2.8 | |
| P / Cash Flow | 12.6 | 12.1 | · | · | · | · | · | 8.2 | 9.6 | 9.6 | 11.0 | 10.6 | |
| P / FCF | 17.1 | 17.5 | · | · | · | · | · | 11.6 | 12.2 | 12.6 | 14.8 | 14.6 | |
| EV / EBITDA | 12.4 | 13.3 | · | · | · | · | · | 8.7 | 10.8 | 9.2 | 11.3 | 8.9 | |
| EV / FCF | 21.3 | 20.9 | · | · | · | · | · | 17.7 | 17.8 | 18.7 | 22.6 | 19.2 | |
| EV / Revenue | 1.8 | 1.8 | · | · | · | · | · | 1.4 | 2.0 | 1.8 | 1.9 | 1.7 | |
| Dividend Yield | 1.2% | 1.3% | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 4.2% | 3.9% | 2.1% | 6.9% | 9.0% | 9.1% | 5.8% | 7.9% | 8.6% | 6.2% | 4.1% | 6.4% | |
| Payout Ratio | 27.5% | 32.6% | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $241M | $243M | $254M | $195M | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.73B | $3.54B | $3.52B | $3.56B | $3.53B | $3.35B | $3.33B | $3.28B | $3.22B | $3.18B | $3.03B | $3.06B | $3.03B | $3.04B | $2.17B | $2.87B | |
| Cost of Revenue | $2.62B | $2.52B | $2.52B | $2.54B | $2.48B | $2.40B | $2.43B | $2.38B | $2.29B | $2.28B | $2.21B | $2.21B | $2.19B | $2.19B | $1.53B | $1.98B | |
| Gross Profit | $1.11B | $1.01B | $993M | $1.03B | $1.05B | $948M | $896M | $904M | $926M | $897M | $821M | $851M | $842M | $850M | $647M | $886M | |
| SG&A Expense | $577M | $551M | $539M | $552M | $579M | $546M | $595M | $569M | $558M | $508M | $533M | $526M | $506M | $457M | $413M | $453M | |
| Operating Income | $452M | $381M | $268M | $397M | $394M | $326M | $216M | $254M | $295M | $321M | $-123M | $252M | $266M | $330M | $-54M | $374M | |
| Interest Expense | $61M | $55M | $55M | $56M | $57M | $56M | $63M | $50M | $48M | $47M | $49M | $50M | $50M | $51M | $49M | $46M | |
| Other Non-op | $-4M | $-13M | $-19M | $-2M | $-33M | $-1M | $16M | $4M | $20M | $20M | $18M | $21M | $-17M | $-7M | $25M | $-18M | |
| Income Tax | $87M | $42M | $26M | $76M | $66M | $62M | $40M | $41M | $62M | $69M | $20M | $55M | $50M | $64M | $-44M | $38M | |
| Net Income | $299M | $278M | $165M | $261M | $238M | $213M | $143M | $169M | $205M | $228M | $-167M | $183M | $189M | $213M | $76M | $353M | |
| EPS (Basic) | $3.66 | $3.37 | $2.01 | $3.14 | $2.85 | $2.54 | $1.72 | $2.02 | $2.44 | $2.71 | $-1.86 | $2.12 | $2.13 | $2.41 | $0.98 | $3.91 | |
| EPS (Diluted) | $3.64 | $3.35 | $1.98 | $3.12 | $2.84 | $2.52 | $1.72 | $2.00 | $2.43 | $2.69 | $-1.85 | $2.11 | $2.12 | $2.39 | $0.97 | $3.90 | |
| Shares (Basic) | 81,700,000 | 82,300,000 | -166,900,000 | 83,100,000 | 83,400,000 | 83,600,000 | -168,300,000 | 84,000,000 | 84,100,000 | 84,100,000 | -176,600,000 | 86,600,000 | 88,700,000 | 88,400,000 | -184,600,000 | 90,200,000 | |
| Shares (Diluted) | 82,000,000 | 82,900,000 | -168,100,000 | 83,700,000 | 83,900,000 | 84,300,000 | -169,000,000 | 84,400,000 | 84,300,000 | 84,700,000 | -177,400,000 | 87,000,000 | 89,000,000 | 89,000,000 | -185,800,000 | 90,700,000 | |
| EBITDA | $452M | $554M | · | $397M | $394M | $493M | · | $254M | $295M | $476M | · | $252M | $266M | $507M | · | $469M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $142M | $981M | $532M | $598M | $647M | $369M | $1.52B | $1.52B | $265M | $99M | $537M | $728M | $1.93B | $394M | $321M | $410M | |
| Receivables | $2.34B | $2.29B | $2.10B | $2.11B | $2.12B | $2.12B | $1.94B | $2.06B | $2.09B | $2.08B | · | $1.96B | $1.90B | $2.34B | · | $2.16B | |
| Inventory | $562M | $498M | $535M | $522M | $508M | $488M | $493M | $483M | $442M | $475M | · | $461M | $488M | $481M | · | $468M | |
| Prepaid Expense | $606M | $630M | $693M | $694M | $655M | $658M | $698M | $685M | $618M | $678M | · | $700M | $660M | $770M | · | $512M | |
| Current Assets | $3.81B | $4.56B | $4.02B | $4.08B | $4.09B | $3.79B | $4.81B | $4.91B | $3.57B | $3.46B | · | $3.95B | $5.12B | $4.70B | · | $4.37B | |
| PP&E (Net) | $3.10B | $3.07B | $3.08B | $3.11B | $3.13B | $3.09B | $3.05B | $3.05B | $2.93B | $2.90B | · | $2.82B | $2.76B | $2.94B | · | $2.88B | |
| PP&E (Gross) | · | · | $6.35B | · | · | · | $6.12B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.27B | · | · | · | $3.07B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.03B | $6.96B | $6.79B | $6.68B | $6.55B | $6.42B | $6.37B | $6.48B | $6.22B | $6.22B | $6.14B | $6.33B | $6.18B | $8.12B | $6.12B | $8.22B | |
| Intangibles | $3.68B | $3.64B | $3.60B | $3.57B | $3.49B | $3.49B | $3.49B | $3.54B | $3.33B | $3.39B | · | $3.28B | $3.15B | $3.91B | · | $3.81B | |
| Other Non-current Assets | $769M | $725M | $751M | $648M | $633M | $647M | $652M | $613M | $639M | $546M | · | $457M | $426M | $459M | · | $451M | |
| Total Assets | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | $17.60B | $18.38B | $18.61B | $16.71B | $16.53B | · | $16.89B | $17.72B | $20.20B | · | $19.83B | |
| Accounts Payable | $688M | $696M | $841M | $668M | $793M | $718M | $876M | $661M | $761M | $696M | · | $691M | $713M | $881M | · | $766M | |
| Accrued Liabilities | $862M | $852M | $848M | $878M | $836M | $770M | $871M | $758M | $708M | $649M | · | $690M | $658M | $930M | · | $1.04B | |
| Short-term Debt | $900.0K | $400.0K | $300.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $500.0K | $800.0K | · | $2M | $2M | $2M | · | $2M | |
| Current Liabilities | $2.12B | $2.64B | $2.82B | $2.63B | $2.72B | $2.06B | $3.33B | $3.41B | $4.06B | $3.94B | · | $2.90B | $2.18B | $2.89B | · | $2.52B | |
| Capital Leases | $661M | $656M | $683M | $692M | $713M | $696M | $676M | $701M | $643M | $625M | · | $662M | $624M | $668M | · | $666M | |
| Other Non-current Liabilities | $718M | $692M | $648M | $639M | $643M | $498M | $517M | $528M | $484M | $468M | · | $423M | $418M | $414M | · | $434M | |
| Total Liabilities | $9.91B | $10.34B | $9.76B | $9.55B | $9.57B | $9.28B | $10.31B | $10.43B | $8.69B | $8.56B | · | $8.99B | $8.91B | $9.84B | · | $9.71B | |
| Long-term Debt | $5.86B | $6.33B | $5.58B | · | · | · | $6.33B | · | · | · | · | · | · | · | · | · | |
| Total Debt | $5.86B | $6.33B | · | $5.08B | $5.08B | $5.57B | · | $5.35B | $3.05B | $3.05B | · | $4.43B | · | $5.05B | · | $5.34B | |
| Common Stock | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $8.70B | $8.78B | $8.64B | $8.70B | $8.50B | $8.46B | $8.30B | $8.28B | $8.18B | $8.06B | · | $8.07B | $8.84B | $10.73B | $10.58B | $10.85B | |
| AOCI | $-102M | $-63M | $-28M | $-42M | $-35M | $-192M | $-262M | $-113M | $-192M | $-185M | $-59M | $-209M | $-154M | $-444M | $-493M | $-761M | |
| Stockholders' Equity | $8.61B | $8.73B | $8.62B | $8.70B | $8.47B | $8.31B | $8.05B | $8.17B | $8.01B | $7.96B | $7.88B | $7.87B | $8.79B | $10.34B | $10.10B | $10.09B | |
| Liabilities + Equity | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | $17.60B | $18.38B | $18.61B | $16.71B | $16.53B | · | $16.89B | $17.72B | $20.20B | · | $19.83B | |
| Shares Outstanding | 80,900,000 | 82,300,000 | 82,200,000 | 83,000,000 | 82,900,000 | 83,800,000 | 83,400,000 | 83,700,000 | 83,800,000 | 84,300,000 | 83,900,000 | 84,900,000 | 88,700,000 | 88,600,000 | 88,200,000 | 89,600,000 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $179M | $173M | $173M | $171M | $170M | $167M | $171M | $162M | $157M | $154M | $146M | $146M | $119M | $142M | $130M | $86M | |
| Stock-based Comp | $35M | $32M | $30M | $29M | $34M | $33M | $27M | $27M | $31M | $32M | $27M | $34M | $27M | $33M | $24M | $16M | |
| Deferred Tax | · | · | $21M | $89M | $-6M | $-6M | $38M | $-20M | $-20M | $-20M | $-60M | $-34M | $14M | $27M | $68M | $-9M | |
| Amort. of Intangibles | $78M | $76M | $73M | $70M | $68M | $70M | $70M | $64M | $62M | $60M | $59M | $56M | $52M | $53M | $28M | $49M | |
| Other Non-cash | · | $-291M | · | · | · | $-388M | · | · | · | $-424M | · | · | · | $-300M | · | · | |
| Operating Cash Flow | $446M | $192M | $614M | $387M | $621M | $18M | $777M | $277M | $561M | $-30M | $580M | $276M | $351M | $121M | $654M | $374M | |
| CapEx | $132M | $121M | $124M | $107M | $78M | $126M | $112M | $116M | $128M | $134M | $167M | $105M | $88M | $78M | $99M | $70M | |
| Investing Cash Flow | $-366M | $-322M | $-390M | $-374M | $-94M | $-336M | $-210M | $-579M | $-185M | $-393M | $-331M | $-488M | $-254M | $-100M | $-273M | $-563M | |
| Stock Repurchased | $354M | $98M | $225M | $25M | $200M | $0 | $75M | $75M | · | · | $-9M | $1.01B | · | · | $-100M | $800M | |
| Net Stock Activity | · | $-98M | · | · | · | · | · | · | · | · | · | · | · | · | · | $-800M | |
| Dividends Paid | $59M | $61M | $59M | $60M | $60M | $62M | $60M | $60M | $60M | $62M | $61M | $64M | $65M | $64M | $64M | $65M | |
| Financing Cash Flow | $-920M | $580M | $-290M | $-60M | $-267M | $-840M | $-547M | $1.55B | $-210M | $-12M | $-446M | $-1.10B | $1.54B | $-61M | $-373M | $-452M | |
| Net Change in Cash | $-839M | $449M | $-66M | $-49M | $278M | $-1.15B | $1M | $1.25B | $166M | $-438M | $-191M | $-1.31B | $1.65B | $-36M | $20M | $-659M | |
| Taxes Paid | $51M | $13M | $11M | $13M | $126M | $20M | $21M | $42M | $132M | $22M | $26M | $48M | $100M | $28M | $83M | $100M | |
| Free Cash Flow | · | $70M | · | · | · | $-108M | · | · | · | $-164M | · | · | · | $27M | · | · |
Rentabilität 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.8% | 28.7% | · | 28.8% | 29.7% | 28.3% | · | 27.6% | 28.8% | 28.2% | · | 27.9% | 27.8% | 25.8% | · | 29.4% | |
| Operating Margin | 12.1% | 10.8% | · | 11.1% | 11.2% | 9.8% | · | 7.7% | 9.2% | 10.1% | · | 8.2% | 8.8% | 9.0% | · | 13.0% | |
| Net Margin | 8.0% | 7.8% | · | 7.3% | 6.7% | 6.4% | · | 5.2% | 6.4% | 7.2% | · | 6.0% | 6.2% | 5.6% | · | 9.8% | |
| EBITDA Margin | 12.1% | 15.7% | · | 11.1% | 11.2% | 14.7% | · | 7.7% | 9.2% | 15.0% | · | 8.2% | 8.8% | 13.4% | · | 13.0% | |
| ROA | 1.6% | 1.5% | · | 1.4% | 1.4% | 1.2% | · | 0.95% | 1.1% | 1.3% | · | 1.0% | · | 1.1% | · | 1.7% | |
| ROE | 3.5% | 3.3% | · | 3.1% | 2.9% | 2.6% | · | 2.1% | 2.2% | 2.7% | · | 2.0% | · | 2.1% | · | 3.4% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.6 | 1.5 | 1.8 | · | 1.4 | 0.9 | 0.9 | · | 1.4 | · | 1.6 | · | 1.7 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | 0.6 | 0.6 | · | 0.9 | · | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.4 | 0.4 | · | 0.6 | · | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.4 | 0.4 | · | 0.6 | · | 0.5 | · | 0.5 | |
| Interest Coverage | 7.4 | 6.9 | · | 7.1 | 6.9 | 5.8 | · | 5.0 | 6.2 | 6.9 | · | 5.0 | 5.3 | 6.7 | · | 10.1 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | · | 0.2 | · | 0.2 | |
| Inventory Turnover | 4.9 | 5.1 | · | 5.1 | 5.2 | 5.0 | · | 5.0 | 5.2 | 4.7 | · | 4.7 | · | 6.2 | · | 5.6 | |
| Receivables Turnover | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.6 | 1.5 | 1.6 | · | 1.5 | · | 1.6 | · | 1.6 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.36B | $13.97B | · | $13.72B | $13.38B | $13.02B | · | $12.74B | $12.49B | $12.30B | · | $12.00B | $11.86B | $12.73B | · | $13.75B | |
| Net Income TTM | $1.08B | $990M | · | $881M | $825M | $815M | · | $786M | $806M | $813M | · | $938M | $1.11B | $1.42B | · | $1.79B | |
| Market Cap | $22.65B | $21.96B | · | $23.83B | $21.76B | $19.50B | · | $18.71B | $17.05B | $18.42B | · | $17.07B | · | $17.46B | · | $15.77B | |
| Enterprise Value | $28.37B | $27.31B | · | $28.31B | $26.19B | $24.70B | · | $22.54B | $19.84B | $21.37B | · | $20.77B | · | $22.12B | · | $20.69B | |
| P/E | 21.6 | 22.6 | · | 27.4 | 26.8 | 24.1 | · | 24.2 | 21.8 | 23.5 | · | 19.1 | 16.9 | 12.8 | · | 9.2 | |
| P/S | 1.6 | 1.6 | · | 1.7 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.4 | · | 1.4 | · | 1.1 | |
| P/B | 2.6 | 2.5 | · | 2.7 | 2.6 | 2.3 | · | 2.3 | 2.1 | 2.3 | · | 2.2 | · | 1.7 | · | 1.6 | |
| P / Cash Flow | · | 114.7 | · | · | · | 1054.2 | · | · | · | -618.0 | · | · | · | 144.1 | · | · | |
| P / FCF | · | 311.5 | · | · | · | -181.4 | · | · | · | -112.6 | · | · | · | 639.7 | · | · | |
| EV / EBITDA | 62.8 | 49.3 | · | 71.4 | 66.4 | 50.1 | · | 88.7 | 67.3 | 44.9 | · | 82.3 | · | 43.6 | · | 44.1 | |
| EV / FCF | · | 387.4 | · | · | · | -229.8 | · | · | · | -130.6 | · | · | · | 810.4 | · | · | |
| EV / Revenue | 2.0 | 2.0 | · | 2.1 | 2.0 | 1.9 | · | 1.8 | 1.6 | 1.7 | · | 1.7 | · | 1.7 | · | 1.5 | |
| Earnings Yield | 4.6% | 4.4% | · | 3.6% | 3.7% | 4.1% | · | 4.1% | 4.6% | 4.3% | · | 5.2% | 5.9% | 7.8% | · | 10.8% | |
| Payout Ratio | · | 22.0% | · | · | · | 28.9% | · | · | · | 27.2% | · | · | · | 30.2% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B |
| Bruttogewinnmarge % | 28.8% | 27.9% | 27.7% | 29.5% | 34.9% |
| Betriebsgewinnmarge % | 9.9% | 8.3% | 6.0% | 11.9% | 20.2% |
| Nettoergebnis | $876M | $746M | $418M | $1.28B | $2.38B |
| Verwässerte EPS | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.7 | 0.5 | 0.5 | 0.5 |
| Liquiditätsgrad | 1.4 | 1.4 | 1.2 | 1.5 | 1.9 |
| Quick Ratio | 0.9 | 1.0 | 0.8 | 0.9 | 1.3 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $1.21B | $1.10B | $874M | $1.47B | $2.65B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.137 Einreicher · $13.9B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 115 (-10 vs. Vorquartal) | 67 (-19 vs. Vorquartal) | 346 (+20 vs. Vorquartal) | 375 (+20 vs. Vorquartal) | +9.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.501.431.120 | 5.362.254 | 10,83% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.322.911.874 | 4.724.673 | 9,54% | Aktien |
| STATE STREET CORP | $1.094.143.680 | 3.907.656 | 7,89% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.030.063.440 | 3.678.798 | 7,43% | Aktien |
| Select Equity Group, L.P. | $554.945.440 | 1.981.948 | 4,00% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $535.196.252 | 1.920.148 | 3,86% | Aktien |
| FMR LLC | $367.740.272 | 1.313.358 | 2,65% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $323.956.098 | 1.156.986 | 2,34% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $236.607.011 | 845.023 | 1,71% | Aktien |
| NORGES BANK | $226.826.040 | 810.093 | 1,64% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $224.168.560 | 800.602 | 1,62% | Aktien |
| Navera Investment Management Ltd. | $218.923.069 | 781.731 | 1,58% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $207.766.160 | 742.022 | 1,50% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $178.985.240 | 639.233 | 1,29% | Aktien |
| BECK MACK & OLIVER LLC | $169.468.040 | 605.243 | 1,22% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $168.221.760 | 600.792 | 1,21% | Aktien |
| River Road Asset Management, LLC | $164.943.800 | 589.085 | 1,19% | Aktien |
| Woodline Partners LP | $155.964.480 | 557.016 | 1,12% | Aktien |
| COOKE & BIELER LP | $147.077.840 | 525.278 | 1,06% | Aktien |
| Madison Asset Management, LLC | $133.459.991 | 476.643 | 0,96% | Aktien |
| EARNEST PARTNERS LLC | $133.421.680 | 476.506 | 0,96% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $128.924.880 | 460.446 | 0,93% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $123.800.108 | 445.164 | 0,89% | Aktien |
| Madison Investment Advisors, LLC | $123.415.073 | 538.178 | 0,89% | Aktien |
| VANGUARD GROUP INC | $116.373.949 | 463.863 | 0,84% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $111.629.302 | 418.385 | 0,80% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $109.064.801 | 401.756 | 0,79% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $90.836.480 | 324.416 | 0,65% | Aktien |
| BANK OF AMERICA CORP /DE/ | $86.222.640 | 307.938 | 0,62% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $74.910.586 | 267.538 | 0,54% | Aktien |
| Squarepoint Ops LLC | $72.362.640 | 258.438 | 0,52% | Aktien |
| Swiss National Bank | $65.077.600 | 232.420 | 0,47% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $63.852.040 | 228.043 | 0,46% | Aktien |
| FAIRVIEW CAPITAL INVESTMENT MANAGEMENT, LLC | $63.265.026 | 225.946 | 0,46% | Aktien |
| JOHNSON INVESTMENT COUNSEL INC | $61.244.676 | 218.731 | 0,44% | Aktien |
| Legal & General Group Plc | $61.101.879 | 218.221 | 0,44% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $58.984.800 | 210.660 | 0,43% | Aktien |
| CAMBIAR INVESTORS LLC | $57.636.600 | 205.845 | 0,42% | Aktien |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $57.282.012 | 204.579 | 0,41% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $55.989.360 | 199.962 | 0,40% | Aktien |
| UBS Group AG | $53.732.840 | 191.903 | 0,39% | Aktien |
| Vanguard Global Advisers, LLC | $49.589.120 | 177.104 | 0,36% | Aktien |
| AMI ASSET MANAGEMENT CORP | $47.755.417 | 170.555 | 0,34% | Aktien |
| BlackRock, Inc. | $45.950.520 | 164.109 | 0,33% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $44.792.720 | 159.974 | 0,32% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $44.597.000 | 159.275 | 0,32% | Aktien |
| California Public Employees Retirement System | $44.287.320 | 158.169 | 0,32% | Aktien |
| RHUMBLINE ADVISERS | $42.279.160 | 150.997 | 0,30% | Aktien |
| Cannell & Spears LLC | $42.010.360 | 150.037 | 0,30% | Aktien |
| Point72 Asset Management, L.P. | $38.484.320 | 137.444 | 0,28% | Aktien |
| DAVIDSON INVESTMENT ADVISORS | $37.211.477 | 132.898 | 0,27% | Aktien |
| Sequoia Financial Advisors, LLC | $35.624.746 | 127.231 | 0,26% | Aktien |
| EVERETT HARRIS & CO /CA/ | $34.912.920 | 124.689 | 0,25% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $32.145.269 | 120.480 | 0,23% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $32.070.360 | 114.537 | 0,23% | Aktien |
| WS MANAGEMENT LLLP | $31.792.880 | 113.546 | 0,23% | Aktien |
| Allianz Asset Management GmbH | $29.362.760 | 104.867 | 0,21% | Aktien |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $28.770.656 | 107.832 | 0,21% | Aktien |
| WEITZ INVESTMENT MANAGEMENT, INC. | $27.734.000 | 99.050 | 0,20% | Aktien |
| AMERIPRISE FINANCIAL INC | $26.314.413 | 93.980 | 0,19% | Aktien |
| Burgundy Asset Management Ltd. | $25.977.610 | 93.448 | 0,19% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $25.697.280 | 91.776 | 0,19% | Aktien |
| Gotham Asset Management, LLC | $25.402.160 | 90.722 | 0,18% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $24.804.360 | 88.587 | 0,18% | Aktien |
| Quantinno Capital Management LP | $24.191.241 | 86.397 | 0,17% | Aktien |
| ZACKS INVESTMENT MANAGEMENT | $23.959.139 | 85.568 | 0,17% | Aktien |
| MCRAE CAPITAL MANAGEMENT INC | $22.704.964 | 81.089 | 0,16% | Aktien |
| ASSETMARK, INC | $22.566.303 | 80.594 | 0,16% | Aktien |
| GOLDMAN SACHS GROUP INC | $21.611.240 | 77.183 | 0,16% | Aktien |
| BARCLAYS PLC | $21.561.960 | 77.007 | 0,16% | Aktien |
| Cerity Partners LLC | $21.505.977 | 76.807 | 0,16% | Aktien |
| Willis Investment Counsel | $21.089.320 | 75.319 | 0,15% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $20.982.380 | 74.937 | 0,15% | Aktien |
| Eurizon Capital SGR S.p.A. | $20.852.912 | 74.478 | 0,15% | Aktien |
| FIL Ltd | $20.182.120 | 72.079 | 0,15% | Aktien |
| AVIVA PLC | $20.142.920 | 71.939 | 0,15% | Aktien |
| Stack Financial Management, Inc | $20.091.299 | 71.755 | 0,14% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $19.724.320 | 70.444 | 0,14% | Aktien |
| Qube Research & Technologies Ltd | $19.709.760 | 70.392 | 0,14% | Aktien |
| HighTower Advisors, LLC | $19.479.174 | 69.568 | 0,14% | Aktien |
| Assenagon Asset Management S.A. | $19.405.400 | 69.305 | 0,14% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $19.013.120 | 67.904 | 0,14% | Aktien |
| PINEBRIDGE INVESTMENTS LLC | $18.194.680 | 64.981 | 0,13% | Aktien |
| Busey Bank | $17.876.320 | 63.844 | 0,13% | Aktien |
| Mill Capital Management, LLC | $17.548.720 | 62.674 | 0,13% | Aktien |
| OAK ASSOCIATES LTD /OH/ | $17.529.960 | 62.607 | 0,13% | Aktien |
| STIFEL FINANCIAL CORP | $17.456.357 | 62.343 | 0,13% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $17.450.975 | 65.406 | 0,13% | Aktien |
| Boston Partners | $17.008.690 | 60.721 | 0,12% | Aktien |
| BROWN ADVISORY INC | $16.968.306 | 60.601 | 0,12% | Aktien |
| LPL Financial LLC | $16.940.224 | 60.501 | 0,12% | Aktien |
| Heron Bay Capital Management | $16.678.445 | 59.566 | 0,12% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $16.604.130 | 59.830 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $15.988.000 | 57.100 | 0,12% | Verkaufsoption |
| FIFTH THIRD BANCORP | $15.700.163 | 56.072 | 0,11% | Aktien |
| Swedbank AB | $15.484.000 | 55.300 | 0,11% | Aktien |
| Ironvine Capital Partners, LLC | $15.349.320 | 54.819 | 0,11% | Aktien |
| FRANKLIN RESOURCES INC | $15.318.240 | 54.708 | 0,11% | Aktien |
| SPEECE THORSON CAPITAL GROUP INC | $15.228.000 | 54.385 | 0,11% | Aktien |
| NATIXIS | $15.115.240 | 53.983 | 0,11% | Aktien |
Unternehmensinsider 66 Insider · 35 Führungskräfte · 24 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul R Kirchgraber | CEO, Covance Drug Development | 19. Mai 2023 M | 12.946 | 0 | 0 | $0 |
| Thomas Pike | Pres & CEO Clinical Business | 9. Januar 2023 A | — | 0 | 0 | $0 |
| John D Ratliff | CEO, Covance Drug Development | 3. April 2019 M | 16.941 | 0 | 0 | $0 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 4. September 2018 M | 1.850 | 0 | 0 | $0 |
| James T. Boyle Jr. | EVP,CEO of LabCorp Diagnostics | 31. März 2016 S | 23.454 | 0 | 0 | $0 |
| Deborah L Keller | CEO, Covance Drug Development | 11. März 2016 M | 19.754 | 0 | 0 | $0 |
| Joseph L Herring | CEO of Covance Drug Division | 31. Juli 2015 M | 10.404 | 0 | 0 | $0 |
| Julia Aijun Wang | Chief Financial Officer, EVP | 11. Februar 2026 M | 1.817 | 0 | 0 | $0 |
| William B Hayes | Chief Financial Officer, EVP | 6. Juni 2014 M | 19.400 | 0 | 0 | $0 |
| Wesley R Elingburg | EVP & Chief Financial Officer | 4. Mai 2005 M | 56.244 | 0 | 0 | $0 |
| Mark S Schroeder | EVP, Pres Diagnostics & COO | 26. März 2026 F | 12.677 | 0 | 0 | $0 |
| Bryan T Vaughn | EVP and President, Diagnostics | 1. Juli 2026 M | 6.746 | 0 | 1 | $-66.968 |
| Kathryn W Kyle | EVP, Chief Legal Officer | 1. Juli 2026 M | 3.904 | 0 | 2 | $-227.413 |
| Jonathan C Meltzer | EVP, Operations | 27. März 2026 S | 3.620 | 0 | 4 | $-298.757 |
| Akinbolade Oyegunwa | EVP, CIO & CTO | 26. März 2026 F | 5.064 | 0 | 0 | $0 |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | 26. März 2026 F | 4.851 | 0 | 0 | $0 |
| Brian J Caveney | EVP, Pres of ED, CMO & CSO | 26. März 2026 F | 36.492 | 0 | 1 | $-429.450 |
| Sandra D Van Der Vaart | EVP, Corporate Affairs | 26. März 2026 F | 6.239 | 0 | 1 | $-156.131 |
| Anita Z Graham | EVP, CHRO | 26. März 2026 F | 5.185 | 0 | 0 | $0 |
| Glenn A Eisenberg | Executive Vice President | 27. März 2025 F | 37.920 | 0 | 0 | $0 |
| Lance Berberian | EVP, Special Advisor, Strategy | 27. März 2025 F | 18.652 | 0 | 0 | $0 |
| Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 27. März 2024 M | 5.461 | 0 | 0 | $0 |
| Judith C Seltz | EVP, CHRO | 30. März 2023 F | 4.182 | 0 | 0 | $0 |
| Lisa J Uthgenannt | Chief Human Resources Officer | 4. September 2019 M | 4.660 | 0 | 0 | $0 |
| Edward T Dodson | Principal Accounting Officer | 1. April 2019 F | 13.663 | 0 | 0 | $0 |
| Samuel F Eberts III | Chief Legal Officer, Secretary | 12. Februar 2019 M | 28.823 | 0 | 0 | $0 |
| Mark E Brecher | CMO, LabCorp Diagnostics | 30. März 2015 M | 5.511 | 0 | 0 | $0 |
| Lidia Fonseca | Chief Information Officer | 28. März 2013 F | 9.087 | 0 | 0 | $0 |
| Andrew Scott Walton | EVP | 9. April 2012 S | 22.298 | 0 | 0 | $0 |
| Don M Hardison | EVP | 31. Dezember 2009 F | 19.928 | 0 | 0 | $0 |
| Goldman Myla Lai | EVP & Chief Medical Officer | 20. November 2008 G | 21.991 | 0 | 0 | $0 |
| William Haas | EVP, Esoterix Business | 7. Mai 2008 A | 44.249 | 0 | 0 | $0 |
| Benjamin R Miller | EVP, Sales & Marketing | 26. März 2008 F | 19.927 | 0 | 0 | $0 |
| Woodrow L Cook | EVP, Eastern Operations | 30. Oktober 2007 M | 12.535 | 0 | 0 | $0 |
| Allen W Troub | EVP, Western Operations | 1. März 2007 F | 12.697 | 0 | 0 | $0 |
| Kerrii B Anderson | Direktor | 17. August 2026 S | 6.563 | 0 | 1 | $-954.060 |
| Kirsten Marie Kliphouse | Direktor | 11. Februar 2026 M | 3.160 | 0 | 0 | $0 |
| Kathryn E Wengel | Direktor | 11. Februar 2026 M | 4.133 | 0 | 0 | $0 |
| Jeffrey A. Davis | Direktor | 11. Februar 2026 M | 5.460 | 0 | 0 | $0 |
| Paul Rothman | Direktor | 11. Februar 2026 M | 2.571 | 0 | 0 | $0 |
| Richelle P Parham | Direktor | 11. Februar 2026 M | 3.366 | 0 | 1 | $-1.782.249 |
| Garheng Kong | Direktor | 11. Februar 2026 M | 13.739 | 0 | 0 | $0 |
| Peter M Neupert | Direktor | 11. Februar 2026 M | 13.784 | 0 | 0 | $0 |
| John H Sampson | Direktor | 10. Februar 2026 A | — | 0 | 0 | $0 |
| Carulla Victor Bulto | Direktor | 10. Februar 2026 A | — | 0 | 0 | $0 |
| Dwight Gary Gilliland | Direktor | 30. Juli 2025 S | 6.656 | 0 | 0 | $0 |
| Sanders R Williams | Direktor | 7. Februar 2024 M | 8.120 | 0 | 0 | $0 |
| Jean Luc Belingard | Direktor | 7. Februar 2024 M | 17.781 | 0 | 0 | $0 |
| David P King | Direktor | 5. Mai 2020 S | 312.554 | 0 | 0 | $0 |
| Robert E Mittelstaedt JR | Direktor | 9. Mai 2019 M | 15.515 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Laboratory Corporation of America Holdings ×4 Einreichungen | 24. Juli 2023 | — | Erste Einreichung | — | SEC |
| Longview Asset Management, LLC /, James A. Star, not individually but solely as President of Longview Asset Management, LLC, Geoffrey F. Grossman, not individually but solely as Trustee of the Edward Memorial Trust ×4 Einreichungen | 23. Januar 2009 | — | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter | 14. Mai 2002 | — | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 18. März 2002 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 28. Februar 2002 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 13. Juni 2001 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 17. Mai 2001 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 176 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 3,85% | 150.479 SH | 8. August 2026 | Täglich |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,76% | 24.022 NS | 30. April 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 2,68% | 9.570 NS | 30. April 2026 | N-PORT |
| CAMX · ADVISORS' INNER CIRCLE FUND | 2,64% | 6.800 NS | 30. April 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,94% | 6.404 SH | 8. August 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,80% | 44.124 SH | 8. August 2026 | Täglich |
| EPMV · Harbor ETF Trust | 1,48% | 255 NS | 30. April 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,43% | 250 NS | 30. April 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,25% | 42.553 NS | 30. April 2026 | N-PORT |
| ZECP · Zacks Trust | 0,79% | 10.344 NS | 31. Mai 2026 | N-PORT |
| ITAN · EA Series Trust | 0,49% | 1.678 NS | 29. Mai 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,46% | 1.301 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,42% | 49.159 SH | 8. August 2026 | Täglich |
| AKAF · ETF Series Solutions | 0,42% | 47 NS | 31. Mai 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,40% | 526.743 SH | 8. August 2026 | Täglich |
| COWZ · Pacer Funds Trust | 0,38% | 268.763 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,37% | 674 NS | 30. April 2026 | N-PORT |
| IMCV · iShares Trust | 0,36% | 13.159 SH | 8. August 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,36% | 6.135 NS | 30. April 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,35% | 5.884 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,34% | 38.214 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,34% | 247.706 SH | 8. August 2026 | Täglich |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,33% | 16.916 NS | 30. April 2026 | N-PORT |
| IXJ · iShares Trust | 0,33% | 43.006 SH | 8. August 2026 | Täglich |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,32% | 2.155 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,31% | 864 NS | 31. Mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,31% | 1.652 NS | 30. April 2026 | N-PORT |
| ABCS · EA Series Trust | 0,30% | 130 NS | 29. Mai 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,28% | 3.600 NS | 31. Mai 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 4.660 NS | 30. April 2026 | N-PORT |
| IWS · iShares Trust | 0,25% | 123.804 SH | 8. August 2026 | Täglich |
| DEUS · DBX ETF Trust | 0,25% | 2.590 NS | 29. Mai 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,24% | 13.814 NS | 30. April 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 3.185 SH | 8. August 2026 | Täglich |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,23% | 3.526 NS | 31. Mai 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 691.006 SH | 8. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,22% | 13.373 SH | 8. August 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,22% | 1.777.108 SH | 8. August 2026 | Täglich |
| DFVE · DoubleLine ETF Trust | 0,22% | 223 NS | 31. März 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 17.572 NS | 30. April 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,20% | 13.515 NS | 31. Mai 2026 | N-PORT |
| SUSA · iShares Trust | 0,19% | 25.113 SH | 8. August 2026 | Täglich |
| IWR · iShares Trust | 0,19% | 334.007 SH | 8. August 2026 | Täglich |
| VLUE · iShares Trust | 0,18% | 54.092 SH | 8. August 2026 | Täglich |
| IMCB · iShares Trust | 0,18% | 9.445 SH | 8. August 2026 | Täglich |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,18% | 4.740.000 | 8. August 2026 | Täglich |
| EVUS · iShares Trust | 0,17% | 2.012 SH | 8. August 2026 | Täglich |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,17% | 895 NS | 30. April 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 4.369 NS | 30. April 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,15% | 34.928 NS | 30. April 2026 | N-PORT |